Vimarsana
Biggest News Aggregation in the World

Page 11 - Ioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ioscience Today - Breaking & Trending Today

ChromaDex to Present at the Lytham Partners Spring 2023 Investor Conference - Vimarsana News

ChromaDex to Present at the Lytham Partners Spring 2023 Investor Conference

ChromaDex Corp. , a global bioscience company dedicated to healthy aging, today announced that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Brianna Gerber, will be... | May 11, 2023

Protein Labeling Global Market is Projected to Reach $3.3 - Vimarsana News

Protein Labeling Global Market is Projected to Reach $3.3

Dublin, May 11, 2023 (GLOBE NEWSWIRE) -- The "Protein Labeling: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's...

Lexaria Bioscience Corp.: Lexaria Bioscience Announces Closing of $2.0 Million Public Offering - Vimarsana News

Lexaria Bioscience Corp.: Lexaria Bioscience Announces Closing of $2.0 Million Public Offering

KELOWNA, BC / ACCESSWIRE / May 11, 2023 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced the closing of

Lexaria Bioscience Corp.: cGMP Manufacturing Complete for Lexaria's Upcoming U.S. Phase 1b Hypertension Clinical Trial - Vimarsana News

Lexaria Bioscience Corp.: cGMP Manufacturing Complete for Lexaria's Upcoming U.S. Phase 1b Hypertension Clinical Trial

DehydraTECH-CBD is currently unique in its evidenced superior power to reduce blood pressure over other oral CBD formulations.DehydraTECH-CBD has demonstrated exceptional safety and tolerability and a

Twist Bioscience to Present at ITF World 2023 - Vimarsana News

Twist Bioscience to Present at ITF World 2023

Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D.,... | May 10, 2023